Bayesian Individual Limits for IGF‐1 Monitoring in Equine Plasma: Implementation in the Equine Biological Passport
Drug Testing and Analysis · 2025
DOI: 10.1002/dta.3795 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Testing and Analysis, 2025. Verfasst von Agnès Barnabé und 7 weiteren Autor:innen. Beteiligte Einrichtung: GIE LCH, Laboratoire des Courses Hippiques, Verrières-le-Buisson, France. Hauptthemen laut MEDLINE: Insulin-Like Growth Factor I, Doping in Sports, Substance Abuse Detection. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: "Institut Français du Cheval et de l'Equitation" (IFCE).
Abstract (Originalsprache)
Despite the International Federation of Horseracing Authorities (IFHA) regulation associated with heavy sanctions, the abuse of prohibited substances must be identified and deterred throughout horses' athletic careers, such as the administration of recombinant growth hormone (rGH). GH is naturally produced in mammal organisms to stimulate growth. Thus, rGH administration can enhance the performance of horses by expanding some physical abilities. As measuring endogenous GH levels is complex, an indirect strategy is to monitor GH‐associated biomarkers in plasma as insulin‐like growth factor 1 (IGF‐1) levels. To prevent these misuses, the Equine Biological Passport (EBP) has been designed in France (GIE LCH) and Australia (ARFL‐Racing NSW) to profile specific biological and chemical parameters in selected racehorses. In this study, we investigated individual limits as a complementary tool to a single limit to supervise the stability of IGF‐1 profile over a racing season. The aim is to design custom limits based on the horse's history to detect any deviation below the single limit. The method was assessed using experimental data and then tested on EBP data from three thoroughbreds and three French trotters. Finally, individual limits have been added to the French EBP for IGF‐1 monitoring.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- GIE LCH, Laboratoire des Courses Hippiques, Verrières-le-Buisson, France.
- Australian Racing Forensic Laboratory, Racing NSW, Sydney, New South Wales, Australia.
ORCID-Profile: Agnès Barnabé, Benoit Loup, Adam Cawley, Vivian Delcourt, Patrice Garcia, Marie-Agnès Popot, Ludovic Bailly-Chouriberry
Förderung
- "Institut Français du Cheval et de l'Equitation" (IFCE)
Zitieren
APA
Barnabé, A., Loup, B., Cawley, A., Delcourt, V., Garcia, P., Popot, M. A., Keledjian, J., & Bailly-Chouriberry, L. (2025). Bayesian Individual Limits for IGF‐1 Monitoring in Equine Plasma: Implementation in the Equine Biological Passport. Drug Testing and Analysis. https://doi.org/10.1002/dta.3795
Vancouver
Barnabé A, Loup B, Cawley A, Delcourt V, Garcia P, Popot MA, et al. Bayesian Individual Limits for IGF‐1 Monitoring in Equine Plasma: Implementation in the Equine Biological Passport. Drug Testing and Analysis. 2025. doi:10.1002/dta.3795
BibTeX
@article{Barnab2025,
author = {Barnabé, Agnès and Loup, Benoit and Cawley, Adam and Delcourt, Vivian and Garcia, Patrice and Popot, Marie-Agnès and Keledjian, John and Bailly-Chouriberry, Ludovic},
title = {Bayesian Individual Limits for IGF‐1 Monitoring in Equine Plasma: Implementation in the Equine Biological Passport},
journal = {Drug Testing and Analysis},
year = {2025},
doi = {10.1002/dta.3795}
}
EUVIMED